• Ugeskrift for laeger · Sep 2007

    [Medical treatment of primary breast cancer: new targeted biological treatments].

    • Michael Andersson and Dorte Lisbet Nielsen.
    • Rigshospitalet, Finsencenter, Onkologisk Klinik, København Ø. michael.andersson@dadlnet.dk
    • Ugeskr. Laeg. 2007 Sep 10; 169 (37): 3082-4.

    AbstractThe monoclonal antibody trastuzumab is at present the only modern targeted treatment which has been studied in early breast cancer. Data are available from four large and one smaller randomised trials where patients with HER2-positive operable breast cancer were randomised to trastuzumab or control in addition to standard adjuvant chemotherapy and endocrine treatment. Trastuzumab therapy resulted in relative risk reductions of 33-59% for recurrence and of 33-41% for death. Trastuzumab has become an integral part of adjuvant therapy in HER2-positive operable breast cancer.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…